New 19-Series solution targets wide range of chemical contaminants SOUTH ORANGE, NJ, October 8, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Nephros, Inc.
Nephros, Inc. (NASDAQ:NEPH ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Judy F. Krandel - Chief Financial Officer Robert Banks - President, CEO & Director Conference Call Participants Thomas McGovern - Unidentified Company Kirin M.
Second-Quarter Net Revenue of $4.4 million; Robust Growth Drives 36% Increase in Net Revenue with Third Consecutive Quarter of Profitability SOUTH ORANGE, NJ, August 7, 2025 – PRISM MediaWire – Nephros, Inc.
SOUTH ORANGE, N.J., July 31, 2025 – PRISM MediaWire – Nephros, Inc.
Nephros, Inc. (NASDAQ:NEPH ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - President & Chief Executive Officer Judy Krandel - Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group Ralph Weil - R. Weil Investment Management Operator Good day, and welcome to the Nephros Inc. Third Quarter 2024 Financial Results Conference Call.
Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript